MVCA Annual Awards Dinner Nominee Cirius Therapeutics Plans IPO

Cirius Therapeutics seeks $86 million IPO. The company was nominated for Capital Event of the Year at the 2017 MVCA Annual Awards Dinner. Founded in 2015, Cirius Therapeutics is a life science startup with research and development operations in Kalamazoo, MI. Formerly known as Octeta, the company is a spin-out of Metabolic Solutions Development Company’s clinical assets…. read more